Silex Systems Ltd : FY Financial Results - Investor Conference Call Notification -190813

Silex Systems Limited (ASX: SLX) (OTCQX: SILXY) will release its financial results for the year ended 30th June 2013 on Friday, 23rd August 2013.

Investors are invited to join a conference call hosted by Dr Michael Goldsworthy, CEO of

Silex at 11.00am (AEST) on Friday, 23rd August 2013. To access the call please use the following details: Conference ID: 3223 1322

Further information on the Company's activities can be found on the Silex website:

www.silex.com.auor by contacting the persons listed below:

Silex Systems Limited (ASX: SLX) (OTCQX: SILXY) is a world leader in research, development and commercialisation of leading edge technologies in key strategic markets, including nuclear power, solar power, semiconductor materials and instrumentation. Silex is a member of the S&P/ASX 300 index and operates four divisions:

Silex has licensed its 'SILEX' laser enrichment technology to Global Laser Enrichment, a business venture comprising GE (51%), Hitachi (25%) and Cameco (24%). Silex and GLE are commercialising the technology for potential deployment in the USA with two sites currently under consideration in North Carolina and Kentucky.

Solar Systems has developed ultra-high efficiency concentrating photovoltaic (CPV) technology based on its proprietary 'Dense Array' dish concentrator system, targeting deployment of utility-scale solar power stations in key global markets.

Translucent has developed novel semiconductor materials based on the 'rare earth oxide' family for application to the manufacturing of next generation devices in the semiconductor, power electronics and photovoltaics industries; and

ChronoLogic has developed the world's first high precision timing and control products based on the

ultra-low cost USB-inSyncTM platform, targeting applications in the electronic instrumentation markets.

For more information on Silex Systems Limited, please visit: www.silex.com.au.

Silex Systems is a research and development Company whose assets are its proprietary rights in
various technologies, including, but not limited to, the SILEX technology, Solar Systems technology and business, Translucent technology and ChronoLogic technology. Several of the Company's technologies are in the development stage and have not been commercially deployed, and therefore are high-risk. Accordingly, the statements in this announcement regarding the future of the Company's technologies and commercial prospects are forward looking and actual results could be materially different from those expressed or implied by such forward looking statements as a result of various risk factors.
Some risk factors that could affect future results and commercial prospects include, but are not limited to: results from the SILEX uranium enrichment commercialisation program; the demand for enriched uranium; the risks associated with the development of Solar Systems technology and related marketing activities; the outcomes of the Company's interests in the development of various semiconductor, photonics, instrumentation and alternative energy technologies; the time taken to develop various technologies; the development of competing technologies; the potential for third party claims against the Company's ownership of Intellectual Property associated with its numerous technologies; the potential impact of government regulations or policies; and the outcomes of various commercialisation strategies undertaken by the Company.

- 2 -

distributed by